Pediatric Oncology
Why Pediatric Oncology Needs Its Own Drug Development Paradigm
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-04Sep 4, 2026
Development CDMO
The Case for Earlier CDMO Involvement in Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-09-26-PA-02Sep 2, 2026
MPS
What Will It Take for Organ-on-Chip Data to Replace Animal Studies?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-18Aug 31, 2026
Chinese Biopharma
Pharmaceutical Innovation in China Takes Center Stage
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-17Aug 25, 2026
Potency Assurance
Why Potency Cannot Be Reduced to a Release Assay in Active Immunotherapy Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-16Aug 24, 2026
Preparedness
Preparing Manufacturing Networks for the Next Pandemic
Pharma's Almanac
PAO-08-26-PA-14Aug 20, 2026
Prevention
Preventive Therapeutics Beyond Vaccines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-13Aug 18, 2026
Mucosal Vaccine
Mucosal Vaccination and the Quest for Better Immunity
David Alvaro, Ph.D.
Pharma's Almanac
PAO-08-26-PA-12Aug 17, 2026
Masked Antibody
Expanding the Oncology Therapeutic Window Through Masked Antibody Technology
Sean McCarthy, Ph.D; David Alvaro, Ph.D.
CytomX Therapeutics
PAO-08-26-CL-09Aug 14, 2026
Vaccine Development
New Vaccine Technologies Expand the Frontiers of Prevention and Treatment
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-11Aug 14, 2026
LAIs
Seven Biotechs Developing Long-Acting Injectable Drugs
Vedangi Joshi
Nice Insight
PAO-08-26-PA-10Aug 10, 2026
Cell Therapy
NueCell Bio Launches as a New Translational Partner to Accelerate Cell Therapies from Discovery into GMP Manufacturing
NueCell Bio
PR-08-26-01Aug 5, 2026
In Vivo CAR-T
Five Companies Bringing In Vivo CAR-T Therapy Closer to the Clinic
Emma Gormlie
Nice Insight
PAO-07-26-PA-13Jul 30, 2026
Combination Products
Collaboration is Key to Successful Injectable Drug–Device Combination Product Development
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-08-26-PA-05Jul 27, 2026
Oncology
Harnessing Macrophage Biology to Overcome Tumor Immune Evasion
Roy Maute, Ph.D.; David Alvaro, Ph.D.
Pheast Therapeutics
PAO-07-26-CL-03Jul 23, 2026
Stem Cells
Stem Cell Therapies: Close to Transforming Promise into Real Patient Outcomes
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-07-26-PA-11Jul 22, 2026
AI-Optimized CLD
From Screening to Design: Can Production Cell Lines Become Programmable Platforms?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-26-PA-19Jul 20, 2026
Rare Cancer CGT
Developing Cell and Gene Therapies for Rare Oncology Applications
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-10Jul 16, 2026
Drug Delivery
Intracellular Delivery: Reaching Targets Beyond the Cell Surface
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-07Jul 14, 2026
Tumor-Agnostic
Moving Beyond Tumor Origin: The Rise of Tissue-Agnostic Oncology
David Alvaro, Ph.D.
Pharma's Almanac
PAO-07-26-PA-05Jul 8, 2026